EUVIMEDEUVIMED entdecken
Crossref

Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia

Jianmin Chen iD, Juan Chen, Baozhu Feng, Meilian Ning, Wanhui Wu, Shiqi Zou

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.2690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Jianmin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Putian University, Fujian, China. Hauptthemen laut MEDLINE: Resveratrol, Xanthine Oxidase, Hyperuricemia, Gout. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Research Projects of Putian University, National Natural Science Foundation of China, Science and Technology Bureau of Putian City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gout predominantly stems from hyperuricemia, precipitating the accumulation of urate crystals and consequent joint inflammation, swelling, and pain, thereby compromising the quality of life and presenting a formidable medical dilemma. Although conventional treatments like allopurinol and febuxostat target uric acid reduction via xanthine oxidase (XO) inhibition, they often entail adverse effects, prompting the exploration of safer alternatives. Resveratrol, a polyphenolic compound abundant in fruits and vegetables, has emerged as a potential XO inhibitor. However, its precise inhibitory mechanisms remain poorly understood. This study aims to comprehensively investigate resveratrol's XO inhibition through mechanistic insights, molecular docking simulations, animal model experiments, and biochemical analysis, contributing valuable insights to the development of novel therapeutics for hyperuricemia and gout.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolXanthine OxidaseHyperuricemiaGoutEnzyme InhibitorsAnimalsMolecular Docking SimulationMiceHumansMale

Stichwörter der Autor:innen

allopurinolhyperuricemiaresveratroluric acidxanthine oxidase

Substanzen

ResveratrolXanthine OxidaseEnzyme Inhibitors

Autor:innen und Institutionen

  • School of Pharmacy, Putian University, Fujian, China.
  • Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Fujian, China.

ORCID-Profile: Jianmin Chen

Förderung

  • Research Projects of Putian University
  • National Natural Science Foundation of China
  • Science and Technology Bureau of Putian City

Zitieren

APA

Chen, J., Chen, J., Feng, B., Ning, M., Wu, W., & Zou, S. (2025). Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2690

Vancouver

Chen J, Chen J, Feng B, Ning M, Wu W, Zou S. Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2690

BibTeX
@article{Chen2025,
  author = {Chen, Jianmin and Chen, Juan and Feng, Baozhu and Ning, Meilian and Wu, Wanhui and Zou, Shiqi},
  title = {Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.2690}
}
Kostenlos starten →